- About
-
The Global ETD Search service is a free service for researchers
to find electronic theses and dissertations. This service is
provided by the
Networked Digital Library of Theses and Dissertations.
Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
Search results
Showing 11 to 20 of 208 (0.011 seconds)| 11 |
Thrombosis and cancer a two way association /Otten, Johannes Martinus Mattheus Bernardus, January 2002 (has links)
Proefschrift Universiteit van Amsterdam. / Auteursnaam op omslag: Hans-Martin Otten. Met lit. opg. - Met samenvatting in het Nederlands.
|
| 12 |
Platelet activation and microparticles in the pericardial cavity during cardiopulmonary bypassMaquelin, Kyra Nicole, January 2003 (has links)
Proefschrift Universiteit van Amsterdam. / Met lit. opg. - Met samenvatting in het Nederlands.
|
| 13 |
Treatment with vitamin K antagonists patients' quality of life, valuations and adherence /Locadia, Mirjam, January 1900 (has links)
Proefschrift Universiteit van Amsterdam. / Met lit. opg. - Met samenvatting in het Nederlands.
|
| 14 |
Experimental studies on the acute thrombogenicity of biologic and synthetic vascular prosthesesBjörck, Claes-Göran. January 1984 (has links)
Thesis (doctoral)--Malmö, 1984.
|
| 15 |
Fibrinogeenverbruik in de zwangerschap fibrinogen consumption during pregnancy /Kuijpers, Johannes Cornelis, January 1982 (has links)
Thesis (doctoral)--Utrecht, 1982.
|
| 16 |
Platelet procoagulant activity and thrombus formationKeuren, Jozef Franciscus Wilhelmus. January 1900 (has links)
Proefschrift Universiteit Maastricht. / Met bibliogr., lit. opg. - Met samenvatting in het Nederlands.
|
| 17 |
The diagnosis of deep venous thrombosisVoorhoeve, Roeland. January 1900 (has links)
Proefschrift Maastricht. / Samenvatting in het Nederlands. Lit. opg. - Met een samenvatting in het Nederlands.
|
| 18 |
The hydrolyser a hydrodynamic thrombectomy catheter to remove thrombi from the cardiovascular system /Ommen, G.V.A. van. January 1998 (has links)
Proefschrift Universiteit Maastricht. / Auteursnaam op omslag: Vincent van Ommen. Met lit. opg. - Met een samenvatting in het Nederlands.
|
| 19 |
The tissue factor pathway of blood coagulation in health and diseaseAriëns, Robert Anton Sybrand. January 1997 (has links)
Proefschrift Universiteit Maastricht. / Met lit. opg. - Met samenvatting in het Nederlands en Italiaans.
|
| 20 |
Associação de doses baixas de heparina não fracionada e de heparina de baixo peso molecular na prevenção de trombose venosa experimental /Carelli, Guareide. January 2003 (has links)
Orientador: Francisco Humberto de Abreu Maffei / Resumo: A heparina é um glicosaminoglicano sulfatado, de cadeia longa, que vem sendo largamente utilizada, desde meados do século passado, no tratamento e profilaxia das tromboses arteriais e venosas e cuja utilização permitiu o desenvolvimento das cirurgias cardíaca e vascular. As heparinas de baixo peso molecular (HBPM) são frações ou fragmentos da heparina separados do complexo polissacarídico por extração com solvente ou por gel filtração, ou por clivagem química ou enzimática aplicada antes dessa separação física. No presente artigo são revistos os diversos aspectos da estrutura, mecanismo de ação, farmacocinética, monitorização laboratorial e aplicações clínicas de ambos os tipos de substâncias, sendo chamada a atenção para as diferenças entre elas. As HBPM tendem a substituir a heparina não fracionada, na maior parte de suas indicações, por serem de mais simples utilização e apresentarem maior eficácia e segurança em algumas indicações, embora sejam de custo mais alto. / Abstract: Heparin is a long sulfated glucosaminoglicane chain has been used in the treatment and prophylaxis of arterial and venous thombosis since the 50's of last century. Its use also aided the development of cardiac and vascular surgery. Low molecular weight heparins (LMWH) are fractions or fragments of heparin separated from the polysaccharide complex by solvent extraction or gel filtration, or by chemical or enzymatic cleavage, before the extraction. In this article the main aspects of structure, mechanism of action, pharmacokinetics, laboratorial control, and clinical indications of both kinds of substances are reviewed and their main differences emphasized. Despite their high cost, LMWH presently tend to substitute unfractionated heparin in the majority of indications because of its simpler use, high efficacy and security in some cases. / Mestre
|
Page generated in 0.016 seconds